Albireo Pharma, Inc. Common Stock: Diferență între versiuni
Albireo Pharma, Inc. Common Stock (modificare)
Versiunea de la data 29 septembrie 2024 04:25
, 29 septembrieThe LinkTitles extension automatically added links to existing pages (https://github.com/bovender/LinkTitles).
Admin (discuție | contribuții) (Pagină nouă: Pagina dedicata companiei Albireo Pharma, Inc. Common Stock listata cu simbolul US.ALBO ==Descriere companie== Albireo Pharma, Inc. (www.albireopharma.com) is a biopharmaceutical company focused on the development and commercialization of bile acid modulators to treat orphan pediatric liver diseases and other liver and gastrointestinal diseases and disorders. The Company's product pipeline includes Bylvay (odevixibat), developed for the treatment of pruritis in patients with...) |
(The LinkTitles extension automatically added links to existing pages (https://github.com/bovender/LinkTitles).) |
||
| Linia 1: | Linia 1: | ||
Pagina dedicata companiei Albireo Pharma, Inc. Common Stock listata cu simbolul US.ALBO | Pagina dedicata companiei Albireo [[PHARMA|Pharma]], Inc. Common Stock listata cu simbolul US.ALBO | ||
==Descriere companie== | ==Descriere companie== | ||